A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Can Pfizer’s GDF15-blocking, appetite-boosting antibody ponsegromab address a cancer-induced wasting syndrome — and help ...

Statin use significantly improved OS for men with metastatic hormone-sensitive and nonmetastatic castrate-resistant prostate ...